The FDA has granted Compass Pathways with a rolling review for a New Drug Application (NDA) for its investigational ...
MUNICH, Germany, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Ketabon GmbH (“Ketabon” or “the Company”), a joint venture between HMNC Brain Health and Develco Pharma, announced today favorable results from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results